Account
News
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
Publications
10.05.2023
ISPOR US 2023: Plenary Session 2 – AI wants ...

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...

Read more
Publications
09.05.2023
ISPOR US 2023: Plenary Session 1 – Global Fo...

Our experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...

Read more
Insider Insights
28.04.2023
The EU Pharmaceutical package missed the mark in t...

EFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe...

Read more
Insider Insights
27.04.2023
The European Commission publish their proposal for...

The European Commission has published their proposal for revised pharmaceutical legislation to cover...

Read more
Case Studies
26.04.2023
Development of an EU go-to-market access plan

Our client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...

Read more
News
25.04.2023
PMA Insights: Week 17

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
25.04.2023
EU aims to revamp European pharmaceutical laws

With country health budgets drained following the pandemic, the European Commission aims to reform E...

Read more
News
30.03.2023
PMA Insights: Week 13 SPECIAL EDITION – Worl...

We summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...

Read more
News
15.03.2023
PMA Insights: Week 11

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.